Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Q&A
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Interview with Saniona's CEO during SCF's 17th Capital Markets Day Life Science

By Isa HuddCommunity Manager
Saniona

Saniona presented at Stockholm Corporate Finance's 17th Capital Markets Days Life Science 2026. We interviewed CEO Thomas Feldthus about, among other things, their success when it comes to partnering with pharma companies, their weigh-loss drug candidate as well as the next strategic plans forward and upcoming phase studies. See

Saniona's presentation at the Life Science Days here. 

00:00 Introduction
00:22 Saniona in a nutshell
00:58 R&D focus on ion channels 01:37 Successful in partnering with pharma companies
02:31 Weigh-loss drug candidate to the market in Mexico
03:15 Next strategic steps and long-term goals

Stay up to date
Company management interviews

Recent videos

Talenom, Webcast, Strategy Review 2026
2026-03-19 09:00 Talenom
Intervju med Resitu Medicals VD under SCF:s 17:e Kapitalmarknadsdag Life Science
2026-03-19 08:10
Interview with Saniona's CEO during SCF's 17th Capital Markets Day Life Science
2026-03-19 08:09 Saniona
Intervju med Ortomas VD under SCF:s 17:e Kapitalmarknadsdag Life Science
2026-03-19 08:07 Ortoma
Intervju med Newbury Pharmaceuticals VD under SCF:s 17:e Kapitalmarknadsdag Life Science
2026-03-19 08:07 Newbury Pharmaceuticals
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.